User Notice: The site will be occasionally unavailable due to scheduled maintenance this weekend. Please accept our apologies for any inconvenience.

0RK9

Alligator Bioscience Ab News - 0RK9

Best deals to access real time data!
Real-time Level 1 for London Stock Exchange
Monthly Subscription
for only
US$29.56
Real-time Level 2 for London Stock Exchange
Monthly Subscription
for only
US$77.61
Real-time London Stock Exchange & FTSE
Monthly Subscription
for only
US$88.69
VAT not included
Stock Name Stock Symbol Market Stock Type Stock ISIN Stock Description
Alligator Bioscience Ab 0RK9 London Ordinary Share SE0000767188 ALLIGATOR BIOSCIENCE ORD SHS
  Price Change Price Change % Stock Price Last Trade
0.00 0.0% 23.00 19:00:00
Open Price Low Price High Price Close Price Previous Close
23.00
more quote information »

Recent News

Date Time Source Heading
5/05/202101:23PRNUSAlligator's mitazalimab shown to enhance cancer vaccine
5/05/202101:21PRNUSAlligator's mitazalimab shown to enhance cancer vaccine
5/04/202101:21PRNUSAlligator Bioscience and BioArctic enter into research..
5/04/202101:18PRNUSAlligator Bioscience and BioArctic enter into research..
4/27/202101:25PRNUSAlligator Bioscience AB: Interim report January-March 2021
4/27/202101:21PRNUSAlligator Bioscience AB: Interim report January-March 2021
4/22/202112:46PRNUSThe Nomination Committee's proposal regarding the board of..
4/22/202112:44PRNUSThe Nomination Committee's proposal regarding the board of..
4/15/202101:21PRNUSAlligator Bioscience and MacroGenics Enter into a Research..
4/15/202101:18PRNUSAlligator Bioscience and MacroGenics Enter into a Research..
4/03/202107:02PRNUSAlligator Bioscience postpones the Annual General Meeting to..
4/03/202106:50PRNUSAlligator Bioscience postpones the Annual General Meeting to..
3/18/202113:13PRNUSAlligator Bioscience appoints Søren Bregenholt as new CEO
3/18/202113:12PRNUSAlligator Bioscience appoints Søren Bregenholt as new CEO
3/18/202110:40PRNUSAlligator Bioscience publishes Annual Report for 2020
3/18/202110:38PRNUSAlligator Bioscience publishes Annual Report for 2020
3/11/202101:21PRNUSMitazalimab synergizes with chemotherapy - Alligator..
3/11/202101:20PRNUSMitazalimab synergizes with chemotherapy - Alligator..
2/26/202101:27PRNUSAlligator Bioscience AB: Year-end Report January-December..
2/26/202101:25PRNUSAlligator Bioscience AB: Year-end Report January-December..
2/23/202109:12PRNUSAlligator Bioscience AB: Last day of trading in paid..
1/27/202111:35PRNUSAlligator Bioscience's rights issue oversubscribed
1/11/202101:48PRNUSThe subscription period in Alligator Bioscience's rights..
12/30/202006:54PRNUSAlligator Bioscience publishes prospectus in connection with..
12/29/202002:25PRNUSAlligator Bioscience recruits new Chief Medical Officer
12/29/202002:23PRNUSAlligator Bioscience recruits new Chief Medical Officer
12/28/202004:26PRNUSAlligator Bioscience submits CTA for the mitazalimab Phase..
12/28/202004:25PRNUSAlligator Bioscience submits CTA for the mitazalimab Phase..
12/10/202001:53PRNUSAlligator Bioscience launches ALLIGATOR-FAB™ - a novel human..
12/10/202001:51PRNUSAlligator Bioscience launches ALLIGATOR-FAB™ - a novel human..
12/04/202002:20PRNUSApproved IND for Alligator Bioscience's CD40-targeting..
12/04/202002:18PRNUSApproved IND for Alligator Bioscience's CD40-targeting..
11/16/202007:18PRNUSAptevo Therapeutics and Alligator Bioscience advancing the..
11/16/202007:16PRNUSAptevo Therapeutics and Alligator Bioscience advancing the..
11/09/202007:15PRNUSAlligator Bioscience presents at the SITC 35th Annual..
11/09/202007:12PRNUSAlligator Bioscience presents at the SITC 35th Annual..
11/05/202001:56PRNUSAlligator Bioscience presents the CD40 antibody mitazalimab..
11/05/202001:49PRNUSAlligator Bioscience presents the CD40 antibody mitazalimab..
10/27/202008:18PRNUSPredicted therapeutic range dose levels reached in ATOR-1017..
10/27/202008:16PRNUSPredicted therapeutic range dose levels reached in ATOR-1017..
10/22/202001:30PRNUSAlligator Bioscience AB (publ): Interim report..
10/22/202001:28PRNUSAlligator Bioscience AB (publ): Interim report..
10/22/202000:25PRNUSAlligator Bioscience focuses on ATOR-1017 and mitazalimab
10/22/202000:23PRNUSAlligator Bioscience focuses on ATOR-1017 and mitazalimab
9/28/202006:25PRNUSAlligator Bioscience appoints Gayle Mills as Chief Business..
9/28/202006:24PRNUSAlligator Bioscience appoints Gayle Mills as Chief Business..
9/24/202010:00PRNUSAlligator Bioscience launches a new immuno-oncology concept
9/24/202009:58PRNUSAlligator Bioscience launches a new immuno-oncology concept
9/16/202001:40PRNUSAlligator Bioscience receives patent approval for the drug..
9/16/202001:39PRNUSAlligator Bioscience receives patent approval for the drug..
See more news about this stock »
Your Recent History
LSE
0RK9
Alligator ..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20210507 10:02:53